You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amlodipine Besylate And Benazepril Hydrochloride patents expire, and what generic alternatives are available?

Amlodipine Besylate And Benazepril Hydrochloride is a drug marketed by Amneal, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Heritage, Lupin Pharms, Norvium Bioscience, Strides Pharma, Teva Pharms, Watson Labs, and Watson Labs Inc. and is included in twelve NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amlodipine Besylate And Benazepril Hydrochloride

A generic version of AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE was approved as amlodipine besylate; benazepril hydrochloride by LUPIN PHARMS on February 5th, 2010.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?
  • What are the global sales for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?
  • What is Average Wholesale Price for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?
Summary for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
US Patents:0
Applicants:10
NDAs:12
Finished Product Suppliers / Packagers: 14
Raw Ingredient (Bulk) Api Vendors: 2
Clinical Trials: 6
Patent Applications: 12
What excipients (inactive ingredients) are in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE excipients list
DailyMed Link:AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE at DailyMed
Drug patent expirations by year for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Recent Clinical Trials for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Novartis PharmaceuticalsPhase 4
Dr. Reddy's Laboratories LimitedPhase 1

See all AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077179-001 May 18, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 079047-001 Jul 5, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077890-003 Oct 14, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077179-004 May 18, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.